Testosterone is the primary androgen hormone driving male health — energy, muscle mass, bone density, libido, mood, and cognitive sharpness. It peaks in your early 20s and declines by approximately 1% every year after that. By the time most men notice the symptoms, they have been accumulating for years.
Testosterone Replacement Therapy (TRT) with Testosterone Cypionate restores circulating testosterone to a healthy physiological range — not above it. The result is a measurable reversal of the symptoms that low testosterone causes: restored energy, improved body composition, increased libido, and better mood. This is not performance enhancement. It is hormone optimization.
Because TRT requires a prescription and lab verification of your testosterone levels before starting, Obsidian Genetics coordinates the full process — labs, physician review, and delivery — in one streamlined protocol.
Includes ongoing provider care & support
Lab review & dose adjustment · Platform access
The numbers behind why low testosterone matters — and what TRT does about it.
Individual results vary. Lab values and symptom response depend on baseline testosterone levels, age, body composition, and other health factors.
Testosterone Cypionate is injected intramuscularly (IM) or subcutaneously (subQ) and absorbed into the bloodstream over 7–14 days. The cypionate ester slows release, producing stable testosterone levels without the peaks and troughs of shorter-acting formulations. Dosing is adjusted based on follow-up labs to maintain levels in the mid-normal physiological range.
Once in circulation, testosterone binds to androgen receptors throughout the body — in muscle cells (stimulating protein synthesis and hypertrophy), bone (increasing density), the brain (improving mood, cognition, and motivation), and the cardiovascular system. The effects are systemic, not localized, because testosterone is a master regulator of male physiology.
Among TRT formulations (gels, patches, pellets, other esters), injectable Testosterone Cypionate offers the most predictable pharmacokinetics, the most adjustable dosing, and the most extensive clinical track record. It is the formulation endorsed by the Endocrine Society and prescribed in the vast majority of physician-supervised TRT protocols in the United States.
Low testosterone presents across multiple systems simultaneously. If several of these sound familiar, a lab test is the logical next step.
TRT requires lab-verified testosterone levels before prescribing. This is not a bureaucratic hurdle — it is the foundation of safe, effective hormone therapy.
We order a comprehensive hormone panel including total testosterone, free testosterone, LH, FSH, estradiol, CBC, and metabolic markers. Labs can be completed at any Quest Diagnostics location or via a home phlebotomy visit at no extra cost.
Your Obsidian Genetics provider reviews your labs and health history via a secure online consultation. If your levels and health profile support TRT, your provider determines the appropriate starting dose of Testosterone Cypionate.
Your Testosterone Cypionate, syringes, and injection supplies are shipped directly to your door in discreet packaging. Your provider reviews your injection technique preference (IM vs subQ) and provides guidance for self-administration.
TRT requires follow-up labs at 6–8 weeks to assess testosterone levels, hematocrit, estradiol, and PSA. Your provider adjusts your dose based on results. Long-term monitoring every 3–6 months keeps your therapy dialed in safely.
Many men report improved energy, better mood, and increased libido within the first 2–4 weeks. Morning erections may return. These early benefits reflect the acute restoration of testosterone levels.
First follow-up bloodwork confirms your testosterone levels are in the target range. Hematocrit, estradiol, and PSA are also checked. Dose adjustment happens here if needed based on lab values and symptom response.
Lean muscle mass begins increasing measurably. Body fat — particularly visceral fat — starts declining. Bone density begins to improve with sustained therapy. These structural changes require consistent treatment over months.
Most TRT patients reach their full optimized state between 6–12 months. With ongoing monitoring and stable levels, the benefits of physiological testosterone restoration become compounding improvements to overall male health.
Testosterone Cypionate is a prescription medication. Your Obsidian Genetics provider will review your full health history before prescribing.
Do not use Testosterone Cypionate if you have a history of prostate cancer or male breast cancer. Testosterone Cypionate is a Schedule III controlled substance and requires a valid prescription from a licensed provider. Use with caution in men with untreated sleep apnea, severe cardiovascular disease, or elevated hematocrit at baseline.
Pricing
One flat rate. Physician supervision, compounded medication, and ongoing support included.
Compounded testosterone cypionate. Subcutaneous or intramuscular injection.
Includes: physician consultation · compounded medication · lab review · ongoing provider support · free shipping
Prescription Medication Notice: Testosterone Cypionate is a Schedule III controlled substance under the Controlled Substances Act and requires a valid prescription from a licensed provider. Obsidian Genetics prescriptions are issued following a clinical review of lab results and health history by a licensed physician. This product is dispensed by a licensed pharmacy and is intended for the specific patient for whom it is prescribed.
Not Medical Advice: The content on this page is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. All Obsidian Genetics prescriptions include provider review and ongoing monitoring. Results are not guaranteed and individual outcomes vary.
Prostate Health: Testosterone therapy is contraindicated in men with known or suspected prostate or breast cancer. Testosterone Cypionate may affect PSA (prostate-specific antigen) levels. Men over 40 and those with a family history of prostate cancer should discuss prostate health screening with their provider before initiating TRT.
Citations: ~1%/year testosterone decline: Harman SM et al., Journal of Clinical Endocrinology & Metabolism (2001). ~39% prevalence over 45: Mulligan T et al., International Journal of Clinical Practice (2006). Clinical reference range: Endocrine Society Guidelines (2018). Symptom outcomes: Isidori AM et al., Clinical Endocrinology (2005).
©2024 Obsidian Genetics. All rights reserved. Obsidian Genetics is a telehealth platform connecting patients with licensed providers.